Section 4: Clinical Pharmacy Services

4CPS-001

A REVISION OF PRESCRIBING PUMP INHIBITOR PRESCRIPTIONS IN INTERNAL MEDICINE AND ADDICTOLOGY DEPARTMENT

4CPS-041

DRUG SURVIVAL OF BIOLOGIC THERAPIES FOR THE TREATMENT OF PSORIASIS

4CPS-233

COVERAGE OF ENERGY AND PROTEIN NEEDS IN PATIENTS WITH KIDNEY FAILURE OR LIVER FAILURE RECEIVING TOTAL PARENTERAL NUTRITION

4CPS-231

THE USE OF CANNABIS OIL IN ONCOLOGICAL PAIN: ANALYSIS OF THE OUTCOMES IN REAL PRACTICE AT A CANCER CENTRE

4CPS-235

A MOBILE TEAM OF CLINICAL PHARMACISTS IN DIGESTIVE AND UROLOGICAL SURGERY UNITS: RESULTS AND SATISFACTION AFTER 9 MONTHS

4CPS-197

ANALYSIS OF PHARMACEUTICAL INTERVENTIONS WITH POTENTIAL TO AVOID DRUG ADVERSE EVENTS IN HOSPITALISED PATIENTS, AND CALCULATION OF AVOIDED COST

4CPS-126

ANALYSIS OF THE EFFECTIVENESS OF PERTUZUMAB AS NEOADYUVANT TREATMENT IN PATIENTS WITH HER2-POSITIVE BREAST CANCER

4CPS-118

LONG-TERM SURVIVAL IN ALK POSITIVE LUNG CANCER: A CASE REPORT

4CPS-092

COLLABORATIVE APPROACH TO IMPROVE ADHERENCE AND RETENTION IN CARE AMONG ILLICIT DRUG USERS WITH HIV/AIDS

4CPS-037

ANALYSIS OF USAGE PROFILE, EFFECTIVENESS AND SAFETY OF ALIROCUMAB IN A TERTIARY HOSPITAL

4CPS-015

PHARMACEUTICAL INTERVENTIONS IN PATIENTS TREATED WITH DIRECT-ACTING ORAL ANTICOAGULANTS ADMITTED IN INTERNAL MEDICINE

4CPS-011

THE PHARMACIST’S ROLE IN THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

4CPS-264

POPULATION PHARMACOKINETIC MODEL OF ETANERCEPT IN RHEUMATIC DISEASE: PROGNOSTIC FACTORS AND DOSE RECOMMENDATIONS

4CPS-262

EVALUATION OF A PHARMACIST-LED DISCHARGE SERVICE

4CPS-261

GRADE OF CHRONICITY IN NONAGENARIANS: CAN WE COMPARE NUMBER AND TYPE OF DRUG INTERVENTIONS?

Pages